| Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in … KA Davies, CM Longshaw, GL Davis, E Bouza, F Barbut, Z Barna, ... The Lancet infectious diseases 14 (12), 1208-1219, 2014 | 429 | 2014 |
| Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes J Freeman, J Vernon, K Morris, S Nicholson, S Todhunter, C Longshaw, ... Clinical Microbiology and Infection 21 (3), 248. e9-248. e16, 2015 | 329 | 2015 |
| Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile … KA Davies, H Ashwin, CM Longshaw, DA Burns, GL Davis, MH Wilcox, ... Eurosurveillance 21 (29), 30294, 2016 | 188 | 2016 |
| Is the GehD lipase from Staphylococcus epidermidis a collagen binding adhesin? MG Bowden, L Visai, CM Longshaw, KT Holland, P Speziale, M Hook Journal of Biological Chemistry 277 (45), 43017-43023, 2002 | 175 | 2002 |
| Unsaturated fatty acids are inhibitors of bacterial conjugation R Fernandez-Lopez, C Machon, CM Longshaw, S Martin, S Molin, ... Microbiology 151 (11), 3517-3526, 2005 | 147 | 2005 |
| The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014 J Freeman, J Vernon, S Pilling, K Morris, S Nicholson, S Shearman, ... Clinical Microbiology and Infection 24 (7), 724-731, 2018 | 129 | 2018 |
| Kytococcus sedentarius, the organism associated with pitted keratolysis, produces two keratin‐degrading enzymes CM Longshaw, JD Wright, AM Farrell, KT Holland Journal of applied microbiology 93 (5), 810-816, 2002 | 107 | 2002 |
| Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review ZR Palacios-Baena, M Giannella, D Manissero, J Rodríguez-Baño, ... Clinical Microbiology and Infection 27 (2), 228-235, 2021 | 94 | 2021 |
| Identification of a second lipase gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal lipases CM Longshaw, AM Farrell, JD Wright, KT Holland Microbiology 146 (6), 1419-1427, 2000 | 87 | 2000 |
| Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure CH Chilton, GS Crowther, J Freeman, SL Todhunter, S Nicholson, ... Journal of Antimicrobial Chemotherapy 69 (2), 451-462, 2014 | 86 | 2014 |
| Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins F Wagenlehner, E Lucenteforte, F Pea, A Soriano, L Tavoschi, VR Steele, ... Clinical Microbiology and Infection 27 (5), 671-686, 2021 | 80 | 2021 |
| Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections M Bassetti, J Rello, F Blasi, H Goossens, G Sotgiu, L Tavoschi, ... International journal of antimicrobial agents 56 (6), 106184, 2020 | 75 | 2020 |
| In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens M Hornsey, C Longshaw, L Phee, DW Wareham Antimicrobial agents and chemotherapy 56 (6), 3080-3085, 2012 | 66 | 2012 |
| A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections EJ Zasowski, M Bassetti, F Blasi, H Goossens, J Rello, G Sotgiu, ... Chest 158 (3), 929-938, 2020 | 58 | 2020 |
| In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection M Hornsey, L Phee, C Longshaw, DW Wareham International journal of antimicrobial agents 41 (3), 285-287, 2013 | 57 | 2013 |
| In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe C Longshaw, D Manissero, M Tsuji, R Echols, Y Yamano JAC-antimicrobial resistance 2 (3), dlaa060, 2020 | 50 | 2020 |
| In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection FJ Candel, AS Henriksen, C Longshaw, Y Yamano, A Oliver Clinical Microbiology and Infection 28 (3), 447. e1-447. e6, 2022 | 35 | 2022 |
| Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model CH Chilton, GS Crowther, SL Todhunter, H Ashwin, CM Longshaw, ... Journal of Antimicrobial Chemotherapy 70 (9), 2598-2607, 2015 | 35 | 2015 |
| Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing E Matuschek, C Longshaw, M Takemura, Y Yamano, G Kahlmeter Journal of Antimicrobial Chemotherapy 77 (6), 1662-1669, 2022 | 33 | 2022 |
| Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes Study Group. The ClosER study: Results from a three-year pan … J Freeman, J Vernon, S Pilling, K Morris, S Nicholson, S Shearman, ... Clin Microbiol Infect 24 (7), 724-31, 2018 | 33 | 2018 |
